Inventor · disambiguated record
Vivek Kumar
Also filed as: KUMAR VIVEK · KUMAR VIVEK A · KUMAR VIVEK ASHOK
13 granted patents·10 pending applications·28 citations·filing 2002–2024
86Inventor score
Files withNEW JERSEY INST TECHNOLOGY4US HEALTH4UNIV JOHNS HOPKINS3UNIV RICE WILLIAM M2COUNCIL SCIENT IND RES1
Top patents by PatentIndex Score
23 records- 0192US9526762B1Multidomain peptides for promoting angiogenesisUNIV RICE WILLIAM M·Filed 2014·Granted Dec 27, 2016·12 cites·18 claims
- 0287US11813340B2PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 14, 2023·2 cites·31 claims
- 0379US11299476B2Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereofUS HEALTH·Filed 2017·Granted Apr 12, 2022·2 cites·14 claims
- 0479US2024408084A1Dopamine d3 receptor selective antagonists/partial agonists and uses thereofUS HEALTH·Filed 2024·Application pending·0 cites
- 0578US12233137B1PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 0678US10632172B2Injectable self-assembling antibacterial peptide hydrogelsNEW JERSEY INST TECHNOLOGY·Filed 2019·Granted Apr 28, 2020·2 cites·17 claims
- 0777US2025177580A1Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0875US12097196B2Dopamine D3 receptor selective antagonists/partial agonists and uses thereofTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2022·Granted Sep 24, 2024·0 cites·17 claims
- 0975US7038078B2Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acidUNIV MARLYLAND BALTIMORE·Filed 2002·Granted May 2, 2006·10 cites·36 claims
- 1062US11337971B2Dopamine D3 receptor selective antagonists/partial agonists and uses thereofUS HEALTH·Filed 2019·Granted May 24, 2022·0 cites·32 claims
- 1161US12162861B2Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereofUS HEALTH·Filed 2022·Granted Dec 10, 2024·0 cites·19 claims
- 1261US7687081B2Herbal formulation useful as local anestheticCOUNCIL SCIENT IND RES·Filed 2004·Granted Mar 30, 2010·0 cites·15 claims
- 1350US2022363662A1Compounds as lxr agonistsINTEGRAL BIOSCIENCES PRIVATED LTD·Filed 2022·Application pending·0 cites
- 1447US2019380957A1Protein Hydrogels For Treatment Of Neovascular DiseaseNEW JERSEY INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 1546US2005187407A1Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acidFiled 2005·Application pending·0 cites
- 1645US12329765B2Targeted nanoparticle for the treatment of traumatic brain injury and other CNS diseasesNEW JERSEY INST TECHNOLOGY·Filed 2022·Granted Jun 17, 2025·0 cites·11 claims
- 1743US2014193477A1Collagen based materials and uses related theretoUNIV EMORY·Filed 2013·Application pending·0 cites
- 1841US2017172953A1Self-assembling drug delivery vehicles with ionically cross-linked drugsUNIV RICE WILLIAM M·Filed 2017·Application pending·0 cites
- 1940US2021177743A1Self-Assembling Multi-Domain Peptide Based HydrogelsNEW JERSEY INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 2039US8022055B2Betulinic acid derivativesDABUR PHARMA LTD·Filed 2005·Granted Sep 20, 2011·0 cites·23 claims
- 2139US2013217871A1Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparationKNOLLER HELMUT·Filed 2011·Application pending·0 cites
- 2238US12428395B2Heterocyclic compounds as kinase inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2020·Granted Sep 30, 2025·0 cites·18 claims
- 2338US2020206233A1Heterocyclic compounds as mutant idh inhibitorsINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vivek Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →